849.90
0.00
(0.00%)
At close: January 30 at 4:32:22 PM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in DKK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jakob Færch Bendtsen | CEO & Director | 578k | -- | 1978 |
Strategic Partners A/S
Visionhouse
Lyskær 8A
Herlev, 2730
Denmark
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 1
Description
Strategic Partners A/S does not have significant operations. Previously, it was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. The company was incorporated in 2009 and is based in Herlev, Denmark.
Corporate Governance
Strategic Partners A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 18, 2024 at 10:59 AM UTC
Strategic Partners A/S Earnings Date
Recent Events
Recent Events Information Not Available